SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-000132
Filing Date
2018-01-16
Accepted
2018-01-16 08:02:32
Documents
30
Period of Report
2017-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannabics_10q-113017.htm 10-Q 416156
2 CERTIFICATION cannabics_10q-ex3101.htm EX-31.1 9583
3 CERTIFICATION cannabics_10q-ex3102.htm EX-31.2 9563
4 CERTIFICATION cannabics_10q-ex3201.htm EX-32.1 4889
5 CERTIFICATION cannabics_10q-ex3202.htm EX-32.2 4813
  Complete submission text file 0001683168-18-000132.txt   1057904

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cnbx-20171130.xml EX-101.INS 77044
7 XBRL SCHEMA FILE cnbx-20171130.xsd EX-101.SCH 9722
8 XBRL CALCULATION FILE cnbx-20171130_cal.xml EX-101.CAL 21903
9 XBRL DEFINITION FILE cnbx-20171130_def.xml EX-101.DEF 13664
10 XBRL LABEL FILE cnbx-20171130_lab.xml EX-101.LAB 79008
11 XBRL PRESENTATION FILE cnbx-20171130_pre.xml EX-101.PRE 58519
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 18527344
SIC: 2834 Pharmaceutical Preparations